Junhe Li
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Phytochemical compounds biological activities
- Ubiquitin and proteasome pathways
Papers in ⓘ
-
- Phytochemical compounds biological activities 5
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 4
- Circular RNAs in diseases 3
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 5
- Co-authors
- Jianping Xiong (16 shared papers)Jun Deng (8 shared papers)Ling Zhang (4 shared papers)Xiaojun Xiang (12 shared papers)Jun Chen (8 shared papers)Lei Wan (1 shared paper)Shanshan Huang (9 shared papers)Fang Wu (1 shared paper)
- Journals
- Journal of Cellular and Molecular Medicine (3 papers)The Prostate (2 papers)Cancer Letters (2 papers)Biochemical and Biophysical Research Communications (2 papers)Cell Death Discovery (1 paper)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Junhe Li
31 papers receiving 792 citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Cancer Research 342
- Molecular Biology 560
- Oncology 172
- Cell Biology 71
- Immunology 74
Countries citing papers authored by Junhe Li
This map shows the geographic impact of Junhe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhe Li more than expected).
Fields of papers citing papers by Junhe Li
This network shows the impact of papers produced by Junhe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhe Li. The network helps show where Junhe Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Junhe Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 102 | |
| 2 | 2012 | 89 | |
| 3 | The role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinoma. | 2014 | 66 |
| 4 | Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2024 | 51 |
| 5 | 2018 | 50 | |
| 6 | UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization. | 2019 | 43 |
| 7 | 2020 | 38 | |
| 8 | 2017 | 35 | |
| 9 | 2020 | 33 | |
| 10 | 2022 | 32 | |
| 11 | 2021 | 30 | |
| 12 | 2020 | 22 | |
| 13 | 2018 | 22 | |
| 14 | 2016 | 20 | |
| 15 | 2020 | 18 | |
| 16 | 2021 | 17 | |
| 17 | 2020 | 16 | |
| 18 | 2018 | 13 | |
| 19 | 2020 | 13 | |
| 20 | 2019 | 13 |
About Junhe Li
Junhe Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Surgery, having authored 31 papers that have together received 795 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers), Phytochemical compounds biological activities (5 papers), Hippo pathway signaling and YAP/TAZ (5 papers), RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (4 papers), Circular RNAs in diseases (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Cancer Research (342 citations), Molecular Biology (560 citations), Oncology (172 citations), Cell Biology (71 citations) and Immunology (74 citations). Junhe Li has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Jianping Xiong, Jun Deng, Ling Zhang, Xiaojun Xiang, Jun Chen, Lei Wan, Shanshan Huang, Fang Wu, Yangyang Yao and Hui Guo. Their work appears in journals such as Journal of Cellular and Molecular Medicine, The Prostate, Cancer Letters, Biochemical and Biophysical Research Communications and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.